9/12/24 18:10 | 8/25/24 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D | | M.d | 0 | 0.00 | 0 | 9 | 8 | 117 | D | | | | | | | | | | | | | | |
5/29/24 19:12 | 5/25/24 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D | | M.d | 0 | 0.00 | 0 | 9 | 9 | 108 | D | | | | | | | | | | | | | | |
2/27/24 19:56 | 2/25/24 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D | | M.d | 0 | 0.00 | 0 | 9 | 10 | 99 | D | | | | | | | | | | | | | | |
11/28/23 19:01 | 11/25/23 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D | | M.d | 0 | 0.00 | 0 | 9 | 11 | 90 | D | | | | | | | | | | | | | | |
8/29/23 18:49 | 8/25/23 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D | | M.d | 0 | 0.00 | 0 | 9 | 12 | 81 | D | | | | | | | | | | | | | | |
5/26/23 19:30 | 5/25/23 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D | | M.d | 0 | 0.00 | 0 | 9 | 14 | 72 | D | | | | | | | | | | | | | | |
2/28/23 18:25 | 2/25/23 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D | | M.d | 0 | 0.00 | 0 | 9 | 17 | 63 | D | | | | | | | | | | | | | | |
11/29/22 17:21 | 11/25/22 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D | | M.d | 0 | 0.00 | 0 | 9 | 20 | 54 | D | | | | | | | | | | | | | | |
8/29/22 21:16 | 8/25/22 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D | | M.d | 0 | 0.00 | 0 | 9 | 25 | 45 | D | | | | | | | | | | | | | | |
3/1/22 21:11 | 2/25/22 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D | | M.d | 0 | 0.00 | 0 | 9 | 50 | 27 | D | | | | | | | | | | | | | | |